MEDTEC Japan is Asia’s largest trade-show dedicated to the design and manufacturing of medical devices. Since its launch in 2009, MEDTEC Japan has shown consistent year-on-year growth. Last year's edition attracted 28’137 potential customers!

-- Organizers are offering special discounts for start-up and university spin-off companies! --

 

Japan’s medical technology market, which is valued at approximately €21.5 billion, represents roughly 10% of the global market. It is the third largest medical device market in the world after the United States and the European Union. During the past 25 years, the size of Japan’s medtech market has doubled. While the market share of domestically made devices has been largely flat, imports have soared.


As part of his initiative, Prime Minister Abe announced that he intends to launch a Japanese version of the NIH, further increasing the focus on the medical industry. 25% of Japan’s population is aged over 65 years – a world record! The Japanese society is not only aged but also wealthy and requests highest quality of health-care and medtech products and costly treatments: An ideal growth-market also for Swiss companies!

 

More details

Find an actor

BioTaiwan 201819.07.2018

BioTaiwan Exhibition 2018 will be held from 19 to 22 July at the TWTC Nangang Exhibition Hall in Taipei, Taiwan.

GENOME JUMPER

Un jeu mobile pour explorer la diversité humaine.

Stolmár & Partner Intellectual Property S.à.r.l.Professional Services & Consulting, Patent & Trademarks

Stolmár & Partner is a steadily growing IP law firm with a strong focus on life sciences (Biotech, pharma, diagnostics), medtech and software protection. S & P counts at present 14 patent, trademark and design attorneys. Our attorneys are admitted to practice before the European Patent Office (EPO), the Swiss Patent and Trademark Office (IGE), the German Patent and Trademark Office (GPTO), EUIPO, WIPO, Switzerland’s and Germany’s Federal Patent Court and the German Federal Supreme Court. Some of our attorneys are also admitted before the, Italian, French and the Austrian Patent and Trademark offices thus offering a seamless truly pan-european one-stop service for our clients. Besides our Geneva office, the headquarter is in Munich in close proximity to the EPO. We have further branch offices in the Lake Constance region (Neuhausen ob Eck) and in Hamburg. Our attorneys and agents are carefully recruited for their technical expertise and industrial experience. Most have earned an advanced technical degree and have significant industrial or academic experience across a wide spectrum of technical areas. While the firm provides a full range of services, it is organized internally around four main practice groups. They are the Chemical/Life Sciences Group, the Electrical/Software, the Medtech/Mechanical Group and the Trademark/Design group. Further S & P advises ist clients in Arbitration, Regulatory affairs and License agreements as well as in IP Due Diligence and expert opinions. Our IP lawyers are trained to evaluate intellectual property in the context of client business issues to ensure alignment with company goals. Strong patent claims constructed around strategic goals are invaluable as our clients commercialize ideas and defend leadership positions via litigation and oppositions. A special focus of the firm is opposition proceedings before the EPO and invalidation proceedings before the German Federal Patent Court. Practicing in Munich and at various european hightech spots is a distinct advantage. The firm’s proximity to the European Patent Office (EPO), the Federal Patent Court and the district court for litigation, allows us the opportunity to help shape the IP landscape. Attorneys can easily conduct in-person interviews at the EPO and form substantive professional relationships with examiners given our regular presence at the EPO.
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn